$1.45
-0.21-12.65%
At close: -
$1.35
-0.1-6.90%
After Hours: 7:59 PM EDT
Applied DNA Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Applied DNA Sciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
APDN | Applied DNA Sciences | -$135.50 | — | — | — | $929.63K | — | — | — | 05/09/2025 | Get Alert |
APDN | Applied DNA Sciences | -$4.50 | -$16.50 | -$28.00 | -69.70% | $891.16K | $1.18M | $1.20M | 1.44% | 02/13/2025 | Get Alert |
APDN | Applied DNA Sciences | -$13.00 | -$17.50 | -$16.00 | 8.57% | $779.74K | $899.00K | $813.11K | -9.55% | 12/17/2024 | Get Alert |
APDN | Applied DNA Sciences | -$240.00 | — | $23.50 | — | $2.92M | — | $797.52K | — | 08/08/2024 | Get Alert |
APDN | Applied DNA Sciences | -$10.00 | -$225.00 | -$135.50 | 39.78% | $4.41M | $950.00K | $929.63K | -2.14% | 05/10/2024 | Get Alert |
APDN | Applied DNA Sciences | -$15.00 | -$15.50 | -$4.50 | 70.97% | $5.26M | $780.00K | $891.16K | 14.25% | 02/08/2024 | Get Alert |
APDN | Applied DNA Sciences | -$3.00 | -$13.50 | -$13.00 | 3.70% | $3.56M | $1.60M | $779.74K | -51.27% | 12/07/2023 | Get Alert |
APDN | Applied DNA Sciences | -$6.50 | -$12.00 | -$0.12 | 99.00% | $4.30M | $2.56M | $2.92M | 13.95% | 08/10/2023 | Get Alert |
APDN | Applied DNA Sciences | -$11.50 | -$10.00 | -$10.00 | 0.00% | $6.15M | $4.12M | $4.41M | 6.99% | 05/11/2023 | Get Alert |
APDN | Applied DNA Sciences | -$31.50 | -$14.50 | -$15.00 | -3.45% | $4.17M | $4.17M | $5.26M | 26.21% | 02/09/2023 | Get Alert |
APDN | Applied DNA Sciences | -$30.00 | -$13.00 | $0.50 | 103.85% | $3.00M | $4.10M | $3.56M | -13.20% | 12/14/2022 | Get Alert |
APDN | Applied DNA Sciences | -$23.00 | -$13.50 | -$6.50 | 51.85% | $1.70M | — | $4.30M | — | 08/11/2022 | Get Alert |
APDN | Applied DNA Sciences | -$16.50 | -$16.50 | -$11.50 | 30.30% | $2.67M | $4.50M | $6.15M | 36.60% | 05/12/2022 | Get Alert |
APDN | Applied DNA Sciences | -$28.00 | -$13.50 | -$31.50 | -133.33% | $1.62M | $4.02M | $4.17M | 3.63% | 02/10/2022 | Get Alert |
APDN | Applied DNA Sciences | -$41.00 | -$18.50 | -$30.00 | -62.16% | $314.00K | $2.30M | $3.00M | 30.43% | 12/09/2021 | Get Alert |
APDN | Applied DNA Sciences | -$36.00 | -$11.00 | -$23.00 | -109.09% | $431.52K | $3.13M | $1.70M | -45.69% | 08/12/2021 | Get Alert |
APDN | Applied DNA Sciences | -$39.50 | -$10.50 | -$16.50 | -57.14% | $552.47K | $2.60M | $2.67M | 2.77% | 05/13/2021 | Get Alert |
APDN | Applied DNA Sciences | -$56.00 | -$27.00 | -$28.00 | -3.70% | $633.52K | $1.36M | $1.62M | 18.82% | 02/11/2021 | Get Alert |
APDN | Applied DNA Sciences | -$72.00 | -$26.00 | -$41.00 | -57.69% | $1.70M | $710.00K | $314.00K | -55.77% | 12/17/2020 | Get Alert |
APDN | Applied DNA Sciences | -$80.00 | -$33.50 | -$36.00 | -7.46% | $2.05M | $800.00K | $431.52K | -46.06% | 08/06/2020 | Get Alert |
APDN | Applied DNA Sciences | -$160.00 | -$38.50 | -$39.50 | -2.60% | $778.47K | $950.00K | $552.47K | -41.84% | 05/14/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-02-13 | $-28.00 | $-16.50 | -69.7 % |
Q4 | 2024-12-17 | $-16.00 | $-17.50 | 8.57 % |
Q2 | 2024-05-10 | $-135.50 | $-225.00 | 39.8 % |
Q1 | 2024-02-08 | $-4.50 | $-15.50 | 71.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2025-02-13 | $1.20M | $1.18M | 1.44 % |
Q4 | 2024-12-17 | $813.11K | $899.00K | -9.55 % |
Q2 | 2024-05-10 | $929.63K | $950.00K | -2.14 % |
Q1 | 2024-02-08 | $891.16K | $780.00K | 14.2 % |
Applied DNA Sciences (APDN) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on February 13, 2025 for Q1.
The Actual EPS was $-28.00, which missed the estimate of $-16.50.
The Actual Revenue was $1.2M, which beat the estimate of $1.2M.
Browse earnings estimates, EPS, and revenue on all stocks.